个性化文献订阅>文章检索

文章名     作者     期刊名     摘要     卷     期         如果没有找到您所需要的文献，请点击 ——此处申请     共6条记录   Dynamics of multiple myeloma tumor therapy with a recombinant measles virus [作者：Dingli, D; Offord, C; Myers, R; Peng, KW; Carr, TW; Josic, K; Russell, SJ; Bajzer, Z,期刊：Cancer gene therapy, 页码：873-882 , 文章类型： Article，,卷期：2009年16-12] Replication-competent viruses are being tested as tumor therapy agents. The fundamental premise of this therapy is the selective infection of the tumor cell population with the amplification of the virus. Spread of the v... Conditional interleukin-12 gene therapy promotes safe and effective antitumor immunity [作者：Komita, H; Zhao, X; Katakam, AK; Kumar, P; Kawabe, M; Okada, H; Braughler, JM; Storkus, WJ,期刊：Cancer gene therapy, 页码：883-891 , 文章类型： Article，,卷期：2009年16-12] We and others have previously demonstrated that (chronic) interleukin (IL)-12 gene therapy delivered intratumorally through ex vivo gene-engineered dendritic cell (DC) is competent to promote the regression of establishe... WT1 gene silencing by aerosol delivery of PEI-RNAi complexes inhibits B16-F10 lung metastases growth [作者：Zamora-Avila, DE; Zapata-Benavides, P; Franco-Molina, MA; Saavedra-Alonso, S; Trejo-Avila, LM; Resendez-Perez, D; Mendez-Vazquez, JL; Isaias-Badillo, J; Rodriguez-Padilla, C,期刊：Cancer gene therapy, 页码：892-899 , 文章类型： Article，,卷期：2009年16-12] The Wilms' tumor gene 1 (WT1) is a universal tumor antigen and consequently a good therapeutic target for the development of gene therapy strategies. Earlier, we reported the in vitro efficacy of WT1 RNAi in the inhibiti... Dendritic cells engineered to secrete anti-GITR antibodies are effective adjuvants to dendritic cell-based immunotherapy [作者：Boczkowski, D; Lee, J; Pruitt, S; Nair, S,期刊：Cancer gene therapy, 页码：900-911 , 文章类型： Article，,卷期：2009年16-12] A number of monoclonal antibodies (mAbs) have been studied for their ability to enhance immune responses. Although these antibodies are effective in pre-clinical and clinical studies, they are costly and have occasionall... New pancreatic carcinoma model for studying oncolytic adenoviruses in the permissive Syrian hamster [作者：Spencer, JF; Sagartz, JE; Wold, WSM; Toth, K,期刊：Cancer gene therapy, 页码：912-922 , 文章类型： Article，,卷期：2009年16-12] Syrian hamster is a practical animal model for studying the systemic effects of oncolytic vectors derived from adenovirus serotype 5 (Ad5). Ad5 replicates well in Syrian hamster tissues, and Syrian hamster cell lines are... Anticancer oncolytic activity of respiratory syncytial virus [作者：Echchgadda, I; Kota, S; DeLa Cruz, I; Sabbah, A; Chang, T; Harnack, R; Mgbemena, V; Chatterjee, B; Bose, S,期刊：Cancer gene therapy, 页码：923-935 , 文章类型： Article，,卷期：2009年16-12] Oncolytic virotherapy is an emerging biotherapeutic platform for cancer treatment, which is based on selective infection/killing of cancer cells by viruses. Herein we identify the human respiratory syncytial virus (RSV) ...